✦ LIBER ✦

Aspects of the future of therapy for patients infected with a high viral load and interferon-resistant subtype of HCV

✍ Scribed by Akihiro Matsumoto; Kendo Kiyosawa

Book ID: 106182558
Publisher: Springer Japan
Year: 2002
Tongue: English
Weight: 37 KB
Volume: 37
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s005350200128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of prolonged interferon therapy

Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load

✍ Yasuji Arase; Kenji Ikeda; Akihito Tsubota; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 163 KB

Predictive factors of virological non-re

Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Early viral kinetics and treatment outco

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load

✍ Akihito Tsubota; Yasuji Arase; Takashi Someya; Yoshiyuki Suzuki; Fumitaka Suzuki 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Abstract An investigation was carried out to determine whether early viral monitoring could predict efficiently the virological response to combination therapy of two different regimens in treatment‐naïve chronic hepatitis C patients infected with genotype 1b with high baseline viral load. Patie

Meta-analysis: the outcome of anti-viral

Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis

✍ A. ANDRIULLI; A. MANGIA; A. IACOBELLIS; A. IPPOLITO; G. LEANDRO; S. ZEUZEM 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Plasma HCV-RNA decline in the first 48 h

Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy

✍ J. E. Arends; J. Cohen Stuart; L. C. Baak; M. E. Van Der Ende; K. J. Van Erpecum 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon